Reportstack has announced a new market research report on Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019. High expenditure on R&D has boosted the growth of the Global Acquired Orphan Blood Diseases Therapeutics Market, which is expected to post a CAGR of 12.29 percent from 2014-2019.
About the Report
According to the report, the high therapeutic value of orphan blood disease drugs combined with the limited patient population have motivated pharmaceutical companies to increase the price of the drugs.
“A 2013 research study conducted in the UK reported that about two-thirds of the members of parliament agreed that there should be no price cap on orphan drugs,”.
The report indicates that untapped markets in many geographical locations will provide immense opportunities for vendors to invest over the projected period. Big players in the market who concentrate on the development of drugs for acquired orphan blood diseases are targeting physicians who are able to prescribe these drugs in place of more invasive surgeries and chemotherapy. This helps manufacturers to increase their product price.
“Soliris, manufactured by Alexion Pharmaceuticals, is the only drug available for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) and also carries the title of the most expensive drug in the world,”.
Complete report available @ Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019.
Key Information Covered in the Report:
Market segmentation, size and forecast through 2019
Market Growth Drivers:
Exemption from Pricing Constraints
For a full detailed list, view our report.
For a full detailed list, view our report.
Market Challenges:
Decreased Investment in Marketing
For a full detailed list, view our report.
For a full detailed list, view our report.
Market Trends:
Entry into Untapped Market
For a full detailed list, view our report.
For a full detailed list, view our report.
Key Vendors:
Alexion Pharmaceuticals
Amgen plc
Celgene Corp.
Incyte Corp.
Amgen plc
Celgene Corp.
Incyte Corp.
Other Prominent Vendors:
CTI BioPharma (Cell Therapeutics)
Eli Lilly
Gilead Sciences
Eli Lilly
Gilead Sciences
About Reportstack:
Reportstack is one of the leading distributors of market research reports in the world today. We host more than 200,000 research products from the world's top publication houses. These publications are distributed amongst 12 top industry verticals and 62 sub verticals, which are then further classified into 257 business categories and 5000 micro markets. The vast selection criterion provides granular data from the length and breadth of all these industries delivering Reportstack members with cutting edge research products to facilitate strategic business decisions.
Contact:
Debora White
Manager - Marketing
debora@reportstack.com
Ph: +1-888-789-6604
Reportstack Market Research
Manager - Marketing
debora@reportstack.com
Ph: +1-888-789-6604
Reportstack Market Research
No comments:
Post a Comment